Skip to main content
. 2016 Feb 26;7(13):16517–16528. doi: 10.18632/oncotarget.7760

Figure 4. The combination of carfilzomib and CUDC-101 increased caspase-dependent apoptosis.

Figure 4

8505c and C-543 cells were treated with drugs at the indicated concentration(s). After 48 h of treatment, the Caspase-Glo 3/7 assay was performed. **P < 0.01, ***P < 0.001.